Hu R - Search Results

1

Identification of NLE1/CDK1 axis as key regulator in the development and progression of non-small cell lung cancer.

Xu P, Wang L, Mo B, Xie X, Hu R, Jiang L, Hu F, Ding F, Xiao H. Xu P, et al. Among authors: hu f, hu r. Front Oncol. 2023 Feb 1;12:985827. doi: 10.3389/fonc.2022.985827. eCollection 2022. Front Oncol. 2023. PMID: 36818671 Free PMC article.

2

Knockdown of the inflammatory factor pentraxin-3 suppresses growth and invasion of lung adenocarcinoma through the AKT and NF-kappa B pathways.

Hu FQ, Qiao T, Xie X, Hu R, Xiao HB. Hu FQ, et al. Among authors: hu r. J Biol Regul Homeost Agents. 2014 Oct-Dec;28(4):649-57. J Biol Regul Homeost Agents. 2014. PMID: 25620175

3

miR-342-3p targets RAP2B to suppress proliferation and invasion of non-small cell lung cancer cells.

Xie X, Liu H, Wang M, Ding F, Xiao H, Hu F, Hu R, Mei J. Xie X, et al. Among authors: hu f, hu r. Tumour Biol. 2015 Jul;36(7):5031-8. doi: 10.1007/s13277-015-3154-3. Epub 2015 Feb 9. Tumour Biol. 2015. PMID: 25663460

4

LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis.

Xie X, Liu HT, Mei J, Ding FB, Xiao HB, Hu FQ, Hu R, Wang MS. Xie X, et al. Among authors: hu fq, hu r. Int J Clin Exp Pathol. 2014 Dec 1;7(12):8881-6. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25674259 Free PMC article.

5

miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN.

Xie X, Liu HT, Mei J, Ding FB, Xiao HB, Hu FQ, Hu R, Wang MS. Xie X, et al. Among authors: hu fq, hu r. Int J Clin Exp Pathol. 2015 Apr 1;8(4):3827-34. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26097565 Free PMC article.

6

TMEM45B, up-regulated in human lung cancer, enhances tumorigenicity of lung cancer cells.

Hu R, Hu F, Xie X, Wang L, Li G, Qiao T, Wang M, Xiao H. Hu R, et al. Among authors: hu f. Tumour Biol. 2016 Sep;37(9):12181-12191. doi: 10.1007/s13277-016-5063-5. Epub 2016 May 26. Tumour Biol. 2016. PMID: 27225290

7

MicroRNA-30e-5p suppresses non-small cell lung cancer tumorigenesis by regulating USP22-mediated Sirt1/JAK/STAT3 signaling.

Xu G, Cai J, Wang L, Jiang L, Huang J, Hu R, Ding F. Xu G, et al. Among authors: hu r. Exp Cell Res. 2018 Jan 15;362(2):268-278. doi: 10.1016/j.yexcr.2017.11.027. Epub 2017 Nov 22. Exp Cell Res. 2018. PMID: 29174979

8

The USP21/YY1/SNHG16 axis contributes to tumor proliferation, migration, and invasion of non-small-cell lung cancer.

Xu P, Xiao H, Yang Q, Hu R, Jiang L, Bi R, Jiang X, Wang L, Mei J, Ding F, Huang J. Xu P, et al. Among authors: hu r. Exp Mol Med. 2020 Jan;52(1):41-55. doi: 10.1038/s12276-019-0356-6. Epub 2020 Jan 20. Exp Mol Med. 2020. PMID: 31956270 Free PMC article.

9

Reverse "L" surgical approach for the management of giant tumors of the cervicothoracic junction.

Zhong Y, Yang X, Jiang L, Hu R, Jiang Z, Wang M. Zhong Y, et al. Among authors: hu r. J Thorac Dis. 2020 Aug;12(8):3995-4001. doi: 10.21037/jtd-20-288B. J Thorac Dis. 2020. PMID: 32944311 Free PMC article.

10

Hsa_circ_0001869 promotes NSCLC progression via sponging miR-638 and enhancing FOSL2 expression.

Xu P, Wang L, Xie X, Hu F, Yang Q, Hu R, Jiang L, Ding F, Mei J, Liu J, Xiao H. Xu P, et al. Among authors: hu f, hu r. Aging (Albany NY). 2020 Nov 20;12(23):23836-23848. doi: 10.18632/aging.104037. Epub 2020 Nov 20. Aging (Albany NY). 2020. PMID: 33221767 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,729 results

Search Page

Filters